Search

Your search keyword '"Tagliabue E"' showing total 750 results

Search Constraints

Start Over You searched for: Author "Tagliabue E" Remove constraint Author: "Tagliabue E"
750 results on '"Tagliabue E"'

Search Results

51. P5400CD34+ cells predict long-term cardiovascular mortality in people with critical limb ischemia: a possible pathogenic role of the microRNA-21/PDCD4 axis

52. ECM Remodeling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics

53. The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoSphere study

54. Effect of number of computed tomography (CT) scans during follow-up (FUP) of patients with clinical stage I (CSI) seminoma: A trial-level meta-analysis

55. Abstract P2-09-03: Identifying clinically relevant subgroups of women with HER2-positive breast cancer: An analysis of Neo-ALTTO using the 41-gene TRAR score

56. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

57. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas

58. Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016

59. Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project

63. Neoadjuvant eribulin following anthracycline and taxane in triple negative breast cancer (HOPE): A multicenter, two stage, phase II trial

66. Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases

68. Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

69. Targeted immunotherapy in multiple sclerosis

71. Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

72. Targeted immunotherapy in multiple sclerosis

73. Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

80. MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project

81. MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project

84. Late abstracts 186–187

85. N-3 fatty acids in patients with multiple cardiovascular risk factors

86. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer

87. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

92. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component

98. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer

Catalog

Books, media, physical & digital resources